SASS - ETF AI Analysis
Top Page
M.D. Sass Concentrated Value ETF (SASS)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Recent Monthly Performance
The ETF has shown a solid gain over the past month, suggesting improving short-term momentum.
Several Strong Top Holdings
Many of the largest positions, including companies like Ametek, Amazon, Primo Brands, Clean Harbors, and Williams, have delivered strong year-to-date gains that support the fund’s results.
Diversified Sector Exposure
Holdings spread across industrials, health care, financials, consumer sectors, energy, real estate, materials, and technology help reduce reliance on any single industry.
Negative Factors
Negative Year-to-Date Performance
The ETF is down so far this year, indicating that it has lagged despite some strong individual holdings.
High Expense Ratio
The fund charges relatively high fees for an ETF, which can eat into long-term returns for investors.
Concentrated and U.S.-Heavy Portfolio
A focus on a limited number of stocks and heavy exposure to U.S. companies increases the impact of stock-specific and domestic market risks.
SASS vs. SPDR S&P 500 ETF (SPY)
AUM77.32M
RegionNorth America
Expense Ratio0.75%
Beta0.70
IssuerM.D. Sass
Inception DateMar 04, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume60
30 Day Avg. Volume3,610
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
29.11Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering21
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SASS Summary
The M.D. Sass Concentrated Value ETF (SASS) is an actively managed fund that focuses on U.S. mid- and large-sized companies the managers believe are undervalued. It doesn’t track a set index, but instead picks a small group of stocks across many sectors, including industrials, health care, and financials. Well-known holdings include Amazon and Capital One Financial. Someone might invest in SASS to seek long-term growth and dividends from value stocks while adding diversification beyond pure tech or growth funds. A key risk is that the fund is concentrated, so a few poorly performing stocks can significantly hurt returns and it can go up and down with the stock market.
How much will it cost me?This ETF has an expense ratio of 0.75%, which means you’ll pay about $7.50 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed, paying a professional team to research and select a smaller group of value stocks they believe can outperform the market.
What would affect this ETF?This ETF could benefit if the U.S. economy stays healthy, industrial and health care companies grow profits, and investors favor value stocks, which may help its concentrated bets in names like Ametek, Henry Schein, and Amazon. On the other hand, a U.S. slowdown, rising interest rates hurting financials and real estate, or poor performance from a few large holdings could weigh heavily on returns because the fund is focused in specific sectors and a relatively small number of stocks.
SASS Top 10 Holdings
SASS leans into U.S. industrials and health care, with Ametek and Clean Harbors acting as key engines of recent gains, both showing rising momentum and solid fundamentals. Quest Diagnostics adds a steady, defensive tilt, while Williams Co offers energy income but is a bit mixed, with leverage and cash flow concerns keeping it from fully pulling its weight. On the weaker side, Capital One and Somnigroup are lagging, hinting that not every value bet is paying off. Amazon is more of a high-profile passenger here, recently losing steam but still supporting the fund’s broader U.S. exposure.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Henry Schein | 7.79% | $6.03M | $9.90B | 25.74% | 74 Outperform | |
| Amazon | 7.18% | $5.55M | $2.66T | 14.23% | 71 Outperform | |
| Primo Brands | 5.95% | $4.60M | $8.77B | -12.95% | 57 Neutral | |
| Ametek | 5.94% | $4.59M | $53.62B | 31.89% | 79 Outperform | |
| Williams Co | 5.74% | $4.44M | $92.92B | 27.19% | 76 Outperform | |
| Capital One Financial | 5.74% | $4.44M | $126.46B | -3.57% | 71 Outperform | |
| Clean Harbors | 5.69% | $4.40M | $16.13B | 33.09% | 78 Outperform | |
| Quest Diagnostics | 5.56% | $4.30M | $22.80B | 20.80% | 79 Outperform | |
| CH Robinson | 5.26% | $4.07M | $23.53B | 101.65% | 72 Outperform | |
| StandardAero, Inc. | 4.74% | $3.66M | $9.10B | -9.02% | 67 Neutral |
SASS Technical Analysis
Positive
―
Price Trends
24.50
Positive
Market Momentum
0.03
Positive
51.59
Neutral
52.16
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SASS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 24.85, equal to the 50-day MA of 24.50, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.03 indicates Positive momentum. The RSI at 51.59 is Neutral, neither overbought nor oversold. The STOCH value of 52.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SASS.
SASS Peer Comparison
Comparison Results
Performance Comparison
SASS
M.D. Sass Concentrated Value ETF
24.78
0.09
0.36%
BAMD
Brookstone Dividend Stock ETF
―
―
―
VUSV
Vanguard Wellington U.S. Value Active ETF
―
―
―
GVLE
Goldman Sachs Value Opportunities ETF
―
―
―
CVAR
Cultivar ETF
―
―
―
USFE
First Eagle US Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents